Becton, Dickinson And Co.

Becton, Dickinson And Co. BDX

Dividend Summary

The next Becton, Dickinson And Co. dividend went ex 8 days ago for 83c and will be paid in 14 days.
The previous Becton, Dickinson And Co. dividend was 83c and it went ex 3 months ago and it was paid 3 months ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 3.4.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Declared
Type Quarterly Quarterly
Per share 83c 83c
Declaration date 25 Jan 2021 (Mon) 27 Apr 2021 (Tue)
Ex-div date 09 Mar 2021 (Tue) 08 Jun 2021 (Tue)
Pay date 31 Mar 2021 (Wed) 30 Jun 2021 (Wed)

Enter the number of Becton, Dickinson And Co. shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
99%
Our premium tools have predicted Becton, Dickinson And Co. with 99% accuracy.
Dividend Yield Today
1.4%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Becton, Dickinson And Co.
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Quarterly 21 Jul 2025 08 Sep 2025 30 Sep 2025 USD Sign up
Forecast Quarterly 22 Apr 2025 06 Jun 2025 30 Jun 2025 USD Sign up
Forecast Quarterly 20 Jan 2025 07 Mar 2025 31 Mar 2025 USD Sign up
Forecast Quarterly 19 Nov 2024 10 Dec 2024 01 Jan 2025 USD Sign up
Forecast Quarterly 22 Jul 2024 06 Sep 2024 30 Sep 2024 USD Sign up
Forecast Quarterly 23 Apr 2024 06 Jun 2024 28 Jun 2024 USD Sign up
Forecast Quarterly 22 Jan 2024 07 Mar 2024 29 Mar 2024 USD Sign up
Forecast Quarterly 21 Nov 2023 07 Dec 2023 29 Dec 2023 USD Sign up
Forecast Quarterly 24 Jul 2023 07 Sep 2023 29 Sep 2023 USD Sign up
Forecast Quarterly 25 Apr 2023 08 Jun 2023 30 Jun 2023 USD Sign up
Forecast Quarterly 23 Jan 2023 09 Mar 2023 31 Mar 2023 USD Sign up
Forecast Quarterly 22 Nov 2022 08 Dec 2022 30 Dec 2022 USD Sign up
Forecast Quarterly 25 Jul 2022 08 Sep 2022 30 Sep 2022 USD Sign up
Forecast Quarterly 26 Apr 2022 08 Jun 2022 30 Jun 2022 USD Sign up
Forecast Quarterly 24 Jan 2022 09 Mar 2022 31 Mar 2022 USD Sign up
Forecast Quarterly 23 Nov 2021 09 Dec 2021 31 Dec 2021 USD Sign up
Forecast Quarterly 26 Jul 2021 08 Sep 2021 30 Sep 2021 USD Sign up
Declared Quarterly 27 Apr 2021 08 Jun 2021 30 Jun 2021 USD 83c 83c 😄
Paid Quarterly 25 Jan 2021 09 Mar 2021 31 Mar 2021 USD 83c 83c 😄
Paid Quarterly 24 Nov 2020 09 Dec 2020 31 Dec 2020 USD 81c 83c 😃
Paid Quarterly 27 Jul 2020 08 Sep 2020 30 Sep 2020 USD 79c 79c 😄
Paid Quarterly 28 Apr 2020 08 Jun 2020 30 Jun 2020 USD 79c 79c 😄
Paid Quarterly 27 Jan 2020 09 Mar 2020 31 Mar 2020 USD 79c 79c 😄
Paid Quarterly 25 Nov 2019 09 Dec 2019 31 Dec 2019 USD 79c 79c 😄
Paid Quarterly 22 Jul 2019 06 Sep 2019 30 Sep 2019 USD 77c 77c 😄
Paid Quarterly 29 Apr 2019 06 Jun 2019 28 Jun 2019 USD 77c
Paid Quarterly 21 Jan 2019 07 Mar 2019 29 Mar 2019 USD 77c
Paid Quarterly 19 Nov 2018 07 Dec 2018 31 Dec 2018 USD 77c
Paid Quarterly 24 Jul 2018 06 Sep 2018 28 Sep 2018 USD 75c
Paid Quarterly 23 Apr 2018 07 Jun 2018 29 Jun 2018 USD 75c
Paid Quarterly 23 Jan 2018 08 Mar 2018 30 Mar 2018 USD 75c
Paid Quarterly 20 Nov 2017 07 Dec 2017 29 Dec 2017 USD 75c
Paid Quarterly 25 Jul 2017 07 Sep 2017 29 Sep 2017 USD 73c
Paid Quarterly 23 May 2017 07 Jun 2017 30 Jun 2017 USD 73c
Paid Quarterly 23 Jan 2017 08 Mar 2017 31 Mar 2017 USD 73c
Paid Quarterly 21 Nov 2016 07 Dec 2016 30 Dec 2016 USD 73c
Paid Quarterly 26 Jul 2016 07 Sep 2016 30 Sep 2016 USD 66c
Paid Quarterly 24 May 2016 07 Jun 2016 30 Jun 2016 USD 66c
Paid Quarterly 08 Mar 2016 31 Mar 2016 USD 66c
Paid Quarterly 23 Nov 2015 08 Dec 2015 31 Dec 2015 USD 66c
Paid Quarterly 04 Sep 2015 30 Sep 2015 USD 60c
Paid Quarterly 05 Jun 2015 30 Jun 2015 USD 60c
Paid Quarterly 27 Jan 2015 06 Mar 2015 31 Mar 2015 USD 60c
Paid Quarterly 25 Nov 2014 08 Dec 2014 31 Dec 2014 USD 60c
Paid Quarterly 22 Jul 2014 05 Sep 2014 30 Sep 2014 USD 54.5c
Paid Quarterly 20 May 2014 05 Jun 2014 30 Jun 2014 USD 54.5c
Paid Quarterly 28 Jan 2014 06 Mar 2014 31 Mar 2014 USD 54.5c
Paid Quarterly 25 Nov 2013 06 Dec 2013 31 Dec 2013 USD 54.5c
Paid Quarterly 23 Jul 2013 05 Sep 2013 30 Sep 2013 USD 49.5c
Paid Quarterly 21 May 2013 05 Jun 2013 28 Jun 2013 USD 49.5c
Paid Quarterly 29 Jan 2013 06 Mar 2013 29 Mar 2013 USD 49.5c
Paid Quarterly 20 Nov 2012 06 Dec 2012 31 Dec 2012 USD 49.5c
Paid Quarterly 05 Sep 2012 28 Sep 2012 USD 45c
Paid Quarterly 06 Jun 2012 29 Jun 2012 USD 45c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 189.0c
100%
2013 99.0c
-47.6%
2014 218.0c
120.2%
2015 240.0c
10.1%
2016 264.0c
10.0%
2017 292.0c
10.6%
2018 300.0c
2.7%
2019 308.0c
2.7%
2020 316.0c
2.6%
2021 Sign Up Required
2022 Sign Up Required
2023 Sign Up Required
2024 Sign Up Required
2025 Sign Up Required

Becton, Dickinson And Co. Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
1.4%
Optimized Yield
Sign Up Required
52 Week High
2.1% on 07 December 2020
52 Week Low
1.4% on 09 March 2021
Next Ex-Div-Date Countdown
Sign Up Required

About Becton, Dickinson And Co.

Becton, Dickinson and Company (BD), incorporated in November 1906, is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. It provides customer solutions that are focused on managing medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; managing drug delivery; aiding anesthesiology care; managing the diagnosis of infectious diseases and cancers; advancing cellular research and applications, and supporting the management of diabetes. The Company caters to markets, such as healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's subsidiaries include Accuri Cytometers, Inc., BD Norge AS, CareFusion Canada 307 ULC, Vital Signs Hong Kong Limited and Dantor S.A.

The Company's operations outside the United States include Europe; the Middle East and Africa (EMA); Greater Asia, which includes Japan and Asia Pacific; Latin America, which includes Mexico, Central America, the Caribbean and South America, and Canada. BD has manufacturing operations outside the United States in Bosnia and Herzegovina, Brazil, Canada, China, Dominican Republic, France, Germany, Hungary, India, Ireland, Italy, Japan, Mexico, the Netherlands, Singapore, Spain and the United Kingdom. It sells its products under various brands, such as BD Hypak, Alaris, Pyxis and Vacutainer, BD Kiestra, BD Max, BD BACTEC, SurePath, Veritor, BD ProbeTec and BD Viper.

BD Medical

The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems.

The diabetes care unit includes various products lines, such as syringes, pen needles and intravenous (IV) sets for the injection or infusion of insulin and other drugs used in the treatment of diabetes. The medication and procedural solutions unit includes various product lines, such as needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products, and surgical and laproscopic instrumentation. The medication management solutions unit includes intravenous medication safety and infusion therapy delivery systems, such as infusion pumps and dedicated disposables; medication compounding workflow systems, and automated medication dispensing and supply management systems. The pharmaceutical systems unit includes prefillable drug delivery systems provided to pharmaceutical companies and sold to end users as drug/device combinations. The businesses served by BD Medical are hospitals and clinics, physicians' office practices, consumers and retail pharmacies, governmental and nonprofit public health agencies, pharmaceutical companies, and healthcare workers.

BD Life Sciences

The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections (HAIs) and cancers. The BD Life Sciences segment produces research and clinical tools that facilitate the study of cells, the components of cells, and to gain an understanding of normal and disease processes. The BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences. The preanalytical systems unit includes integrated systems for specimen collection, and safety-engineered blood collection products and systems. The diagnostic systems unit includes automated blood culturing and tuberculosis culturing systems, molecular testing systems for infectious diseases and women's health, microorganism identification and drug susceptibility systems, liquid-based cytology systems for cervical cancer screening, rapid diagnostic assays, microbiology laboratory automation, and plated media. The biosciences unit includes fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, human immunodeficiency virus (HIV) and transplantation diagnostic/monitoring reagents and analyzers, and cell culture media supplements for biopharmaceutical manufacturing. The primary businesses served by BD Life Sciences are hospitals, laboratories and clinics; blood banks; healthcare workers; public health agencies; physicians' office practices; academic and government institutions, and pharmaceutical and biotechnology companies.

Sector
Pharmaceuticals & Biotechnology
Country
United States
Share Price
$241.44 (yesterday's closing price)
Shares in Issue
270 million
Market Cap
$65.2bn
Dividend Cover
How many times is the dividend covered by company income. A cover of 1 means all income is paid out in dividends
3.4
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
7
Market Indices
S&P 500
No articles found